M. Simonsson

发表

History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response

C. Ingvar, C. Rose, Louise Huzell, 2015, Breast Cancer Research and Treatment.

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients

K. Jirström, C. Ingvar, C. Rose, 2015, BMC Clinical Pathology.

Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort

K. Jirström, C. Ingvar, C. Rose, 2015, Clinical Cancer Research.

Excessive milk production during breast-feeding prior to breast cancer diagnosis is associated with increased risk for early events

C. Ingvar, C. Rose, M. Simonsson, 2013, SpringerPlus.

Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort

C. Ingvar, C. Rose, M. Persson, 2016, British Journal of Cancer.

The prevalence of rheumatoid arthritis in Sweden.

L. Jacobsson, S. Bergman, I. Petersson, 1999, Scandinavian journal of rheumatology.

Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events

C. Ingvar, P. Bendahl, C. Rose, 2014, SpringerPlus.

High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy–Treated Patients—Results from a Population-Based Breast Cancer Cohort

K. Jirström, C. Ingvar, C. Rose, 2016, Clinical Cancer Research.

Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status

C. Ingvar, C. Rose, M. Simonsson, 2013, Cancer Causes & Control.

Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease

P. Geborek, T. Saxne, M. Kapetanovic, 2010, Scandinavian journal of rheumatology.

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

C. Ingvar, C. Rose, Srinivas Veerla, 2016, BMC Cancer.

Effects of affinity on binding of HER2-targeting Affibody molecules: model experiments in breast cancer spheroids.

M. Simonsson, T. Tran, O. F. Qvarnström, 2011, International journal of oncology.

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment

K. Jirström, C. Ingvar, C. Rose, 2018, Front. Endocrinol..

Coactivator-Dependent Acetylation Stabilizes Members of the SREBP Family of Transcription Factors

J. Ericsson, E. Grönroos, M. Simonsson, 2003, Molecular and Cellular Biology.

Integration of Tumor and Host Factors – Implications for Breast Cancer Prognosis

M. Simonsson, 2016 .

Protein Acetylation – A Multifunctional Regulator of TGF

M. Simonsson, 2007 .

A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis

R. Palmer, B. Ringertz, J. Kirwan, 2004, Annals of the rheumatic diseases.

Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer

C. Ingvar, C. Rose, L. Zeng, 2015, Clinical Cancer Research.

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients

K. Jirström, C. Ingvar, C. Rose, 2018, Front. Oncol..

The DNA Binding Activities of Smad2 and Smad3 Are Regulated by Coactivator-mediated Acetylation*

C. Heldin, J. Ericsson, E. Grönroos, 2006, Journal of Biological Chemistry.

Á H 2 AX and cleaved PARP-1 as apoptotic markers in irradiated breast cancer BT 474 cellular spheroids

I. Turesson, M. Simonsson, O. F. Qvarnström, 2022 .

The Balance between Acetylation and Deacetylation Controls Smad7 Stability*

Maria Simonsson, C. Heldin, J. Ericsson, 2005, Journal of Biological Chemistry.

Characterization of a Trypanosoma cruzi acetyltransferase: cellular location, activity and structure.

D. Nilsson, C. Branche, L. Åslund, 2007, Molecular and biochemical parasitology.

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

C. Ingvar, C. Rose, Srinivas Veerla, 2016, BMC Cancer.

Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients

C. Ingvar, C. Rose, M. Simonsson, 2014, International journal of cancer.

Caffeine and caffeic acid inhibit growth and modify estrogen receptor ( ER ) and insulin-like growth factor I receptor ( IGF-IR ) levels in human breast cancer

C. Ingvar, C. Rose, L. Zeng, 2014 .

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer

K. Jirström, C. Ingvar, C. Rose, 2017, Front. Endocrinol..

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups

K. Jirström, C. Ingvar, C. Rose, 2016, Oncotarget.

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis

C. Ingvar, K. Isaksson, C. Rose, 2018, Cancer Causes & Control.

gammaH2AX and cleaved PARP-1 as apoptotic markers in irradiated breast cancer BT474 cellular spheroids.

I. Turesson, M. Simonsson, O. F. Qvarnström, 2009, International journal of oncology.

The prognostic impact of COX‐2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size

K. Jirström, C. Ingvar, C. Rose, 2017, International journal of cancer.

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort

C. Ingvar, C. Rose, M. Simonsson, 2014, BMC Cancer.